These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 14533451)
1. Cancer pharmacogenomics: SNPs, chips, and the individual patient. McLeod HL; Yu J Cancer Invest; 2003; 21(4):630-40. PubMed ID: 14533451 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy. Evans WE Ther Drug Monit; 2004 Apr; 26(2):186-91. PubMed ID: 15228163 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm. Krynetski EY; Evans WE Pharm Res; 1999 Mar; 16(3):342-9. PubMed ID: 10213363 [TBL] [Abstract][Full Text] [Related]
4. Cancer pharmacogenomics: current and future applications. Watters JW; McLeod HL Biochim Biophys Acta; 2003 Mar; 1603(2):99-111. PubMed ID: 12618310 [TBL] [Abstract][Full Text] [Related]
5. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine. Dervieux T; Médard Y; Verpillat P; Guigonis V; Duval M; Lescoeur B; Suciu S; Vilmer E; Jacqz-Aigrain E Leukemia; 2001 Nov; 15(11):1706-12. PubMed ID: 11681411 [TBL] [Abstract][Full Text] [Related]
6. The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics. McLeod HL; Siva C Pharmacogenomics; 2002 Jan; 3(1):89-98. PubMed ID: 11966406 [TBL] [Abstract][Full Text] [Related]
7. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. Relling MV; Hancock ML; Rivera GK; Sandlund JT; Ribeiro RC; Krynetski EY; Pui CH; Evans WE J Natl Cancer Inst; 1999 Dec; 91(23):2001-8. PubMed ID: 10580024 [TBL] [Abstract][Full Text] [Related]
8. [Relationship between single nucleotide polymorphisms in thiopurine methyltransferase gene and tolerance to thiopurines in acute leukemia]. Ma XL; Zhu P; Wu MY; Li ZG; Hu YM Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):929-33. PubMed ID: 14723818 [TBL] [Abstract][Full Text] [Related]
9. Drug methylation in cancer therapy: lessons from the TPMT polymorphism. Krynetski E; Evans WE Oncogene; 2003 Oct; 22(47):7403-13. PubMed ID: 14576848 [TBL] [Abstract][Full Text] [Related]
10. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783 [TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Bosch TM; Meijerman I; Beijnen JH; Schellens JH Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759 [TBL] [Abstract][Full Text] [Related]
12. Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia. Albayrak M; Konyssova U; Kaya Z; Gursel T; Guntekin S; Percin EF; Kocak U Cancer Chemother Pharmacol; 2011 Nov; 68(5):1155-9. PubMed ID: 21400026 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy. Bosch TM Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics: unlocking the human genome for better drug therapy. McLeod HL; Evans WE Annu Rev Pharmacol Toxicol; 2001; 41():101-21. PubMed ID: 11264452 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Evans WE; Johnson JA Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642 [TBL] [Abstract][Full Text] [Related]